| COVID-19 |
1 |
1 |
| Biomarker |
0 |
0.99 |
| Plasma |
0 |
0.98 |
| Hospital |
0 |
0.2 |
| Brain |
0 |
0.14 |
| Pandemic |
0 |
0.14 |
| Intensive Care Unit |
0 |
0.12 |
| Care and Maintenance of Vision |
0 |
0.11 |
| Cataract |
0 |
0.11 |
| Cerebrovascular Accident |
0 |
0.11 |
| Headache |
0 |
0.11 |
| Mild Cognitive Impairment |
0 |
0.11 |
| Cognitive Impairment |
0 |
0.1 |
| A-Scan Biometry |
0 |
0.07 |
| Canada |
0 |
0.07 |
| Central Nervous System |
0 |
0.07 |
| Fatigue |
0 |
0.07 |
| Hemorrhage |
0 |
0.07 |
| Impairment |
0 |
0.07 |
| Ischemia |
0 |
0.07 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.07 |
| Scan |
0 |
0.07 |
| Seizure |
0 |
0.07 |
| Students |
0 |
0.07 |